Providian's News Section:

Stock Business

Tue, 22 Jul 2014 18:27:57 GMT
Contrarian's case: Why US could dip into recession - -College Station EagleUnlike their U.S. counterparts, European banks are still stuck with too many bad loans from the financial crisis. Business debt there is too high. And confidence is fleeting, as investors saw earlier this month when stocks sold off on worries over the . .

Mon, 14 Jul 2014 20:12:57 GMT
Mylan to Acquire Abbott's Non-US Businesses in $5.3 Billion Stock Deal - Pharmaceutical Technology Magazine
New York TimesMylan to Acquire Abbott's Non- - Pharmaceutical Technology MagazineMylan Inc. announced on July 14 that it has entered into an agreement with Abbott to acquire Abbott's non-US developed markets specialty and branded generics business in an all-stock transaction. Upon closing, Abbott will receive 105 million shares of .Mylan to Buy Abbott's Generic Drug Business Outside US for $5.3 BillionNew York TimesAbbott, Mylan Join Forces to Dodge US Taxes24/7 Wall St.Mylan to buy Abbott generics, cut taxes, in $5.3 billion dealReutersBoston Globe -Business Insiderall 211 news articles .

Wed, 23 Jul 2014 09:18:45 GMT
Europe edges up on earnings, risk aversion remains - Reuters India
Gains were more muted in Europe - where the pace of economic recovery and the impact of a Russia slowdown have worried investors - than in much of Asia or the United States, where stocks hit fresh milestones and where earnings from bellwethers such as .Asia stocks rise as focus shifts from risk aversion, Aussie spikesTODAYonlineall 7,905 news articles .

Mon, 21 Jul 2014 21:02:21 GMT
NEW YORK — U.S. stocks slipped on Monday as investors remained cautious about instability in Ukraine and Gaza, though the three major indexes ended well off their lows, a sign that some appetite for riskier assets remained. The S& P 500 fell as much as .Wall Street gains on earnings & data, conflicts still eyedBusiness StandardUS STOCKS-Wall St gains on earnings, data; conflicts still eyedReuters UKall 183 news articles .

Tue, 22 Jul 2014 00:42:27 GMT
Asian Stock Markets Push Higher - Business Insider
TOKYO (Reuters) - Asian stocks edged up in early trading on Tuesday, though the upside was capped by lingering concerns about the Ukraine crisis and violence in Gaza which pressured U.S. yields and the dollar. Malaysia has reached an agreement with . .

Fri, 04 Jul 2014 18:54:40 GMT
The Dow Jones Industrial Average, which measures the share price performance of 30 blue-chip companies, broke through 17,000 for the first time. It closed at 17,068.26, up 92.02 points, or 0.54 per cent. The Standard & Poor's 500-stock index, a broader .Dow Closes Above 17000 for First TimeNew York Timesall 885 news articles .

Tue, 22 Jul 2014 21:25:25 GMT
Portland Business Journal (blog)Portland-based Galena Biopharma Inc. announced today that it has licensed the U.S. rights for Zuplenz, an oral film similar to Listerine strips that contain a powerful anti-nausea medication, ondansetron. There's a $1 billion market for the class of .

Wed, 25 Jun 2014 17:21:41 GMT
European stock markets have closed in negative territory as the United States recorded its biggest contraction in five years. London's FTSE 100 index of top companies lost 0.79 per cent to end the day at 6,733.62 points. Frankfurt's DAX 30 slumped 0.71 . .

Tue, 22 Jul 2014 16:27:12 GMT
Ackman Attacks, Herbalife Ltd. Responds, Stock Rises - ValueWalk
Herbalife Ltd. (NYSE:HLF) released the economic analysis of Dr. Walter H. A. Vandaele, managing director of Navigant Economics regarding its business operations in the United States in response to the recent attacks of activist investor, Bill Ackman.Ackman goes after Herbalife's nutrition clubsBoston GlobeThe 'Death Blow' to Herbalife Promised by William Ackman Falls Short of Its .New York Timesall 349 news articles .

Tue, 22 Jul 2014 13:30:18 GMT
Netflix's Europe expansion seen eating into profits - RBC forecast that longer term, margins in the business would be similar to that in its U.S. business, which the brokerage said were 27.9 percent in the latest quarter. RBC kept its "outperform" rating on the stock and raised its price target to $530 .